Results 131 to 140 of about 5,073 (155)
Some of the next articles are maybe not open access.
Annals of Surgical Oncology, 2012
To determine whether abdominal and pelvic magnetic resonance imaging (MRI) with diffusion-weighted and dynamic gadolinium-enhanced imaging can be used to accurately calculate the peritoneal cancer index (PCI) before surgery compared to the PCI tabulated at surgery.Thirty-three patients underwent preoperative MRI followed by cytoreductive surgery for ...
Russell N, Low, Robert M, Barone
openaire +2 more sources
To determine whether abdominal and pelvic magnetic resonance imaging (MRI) with diffusion-weighted and dynamic gadolinium-enhanced imaging can be used to accurately calculate the peritoneal cancer index (PCI) before surgery compared to the PCI tabulated at surgery.Thirty-three patients underwent preoperative MRI followed by cytoreductive surgery for ...
Russell N, Low, Robert M, Barone
openaire +2 more sources
Liver-directed surgical procedures during cytoreductive surgery for stage IV ovarian cancer
European Journal of Surgical OncologyThe incorporation of liver-directed surgical procedures into cytoreductive surgery represents a challenge in stage IV epithelial ovarian cancer. Overall, 49 patients undergoing primary or interval debulking surgery with at least one hepatobiliary procedure were retrospectively analyzed.
Giorgio Bogani +5 more
openaire +3 more sources
Journal of Surgical Oncology, 2009
AbstractCytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for the therapy of peritoneal carcinomatosis are associated with substantial morbidity and acceptable mortality. Patient selection, learning curve, patient warming, and reduced blood loss are the main factors to decrease morbidity.
openaire +2 more sources
AbstractCytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for the therapy of peritoneal carcinomatosis are associated with substantial morbidity and acceptable mortality. Patient selection, learning curve, patient warming, and reduced blood loss are the main factors to decrease morbidity.
openaire +2 more sources
International Journal of Gynecological Cancer, 2023
Ester Martínez Lamela +3 more
openaire +1 more source
Ester Martínez Lamela +3 more
openaire +1 more source
International Journal of Gynecological Cancer, 2023
Jesús Molero Vílchez +4 more
openaire +1 more source
Jesús Molero Vílchez +4 more
openaire +1 more source
Surgical cytoreduction in stage IV endometrioid endometrial carcinoma
Gynecologic Oncology, 2011Dennis Chi, M M Leitao, D S Chi
exaly
Splenectomy and Surgical Cytoreduction for Ovarian Cancer
Gynecologic Oncology, 2000Beth Karlan +2 more
exaly

